Hasan Alawi

4.0k total citations
8 papers, 156 citations indexed

About

Hasan Alawi is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pharmacology. According to data from OpenAlex, Hasan Alawi has authored 8 papers receiving a total of 156 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Hasan Alawi's work include Diabetes Treatment and Management (7 papers), Metabolism, Diabetes, and Cancer (5 papers) and Diabetes Management and Research (5 papers). Hasan Alawi is often cited by papers focused on Diabetes Treatment and Management (7 papers), Metabolism, Diabetes, and Cancer (5 papers) and Diabetes Management and Research (5 papers). Hasan Alawi collaborates with scholars based in Spain, Finland and Switzerland. Hasan Alawi's co-authors include Peter Diem, Péter Kempler, Tadej Battelino, W Grzeszczak, İlhan Satman, Oliver Schnell, Antonio Ceriello, Kari Harno, Bruno Vergès and Anne Felton and has published in prestigious journals such as Diabetes Care, International Journal of Environmental Research and Public Health and Diabetes Technology & Therapeutics.

In The Last Decade

Hasan Alawi

8 papers receiving 148 citations

Peers

Hasan Alawi

EDM

MB

SURGE

GENET

PHYSI

Masahiko Takai Japan

Zsolt Gaál Hungary

Amer Rassam United States

Xiaolin Dong China

Thomas Segiet Germany

Martin Tze Wah Kueh Malaysia

Turner Rc United Kingdom

Jaako Tuomilehto Finland

Hinde Iraqi Morocco

Andreas Klinge Germany

Masahiko Takai Japan

Hasan Alawi

137 ×1.0

EDM

24 ×0.9

MB

21 ×0.9

SURGE

8 ×0.3

GENET

17 ×0.8

PHYSI

Citations per year, relative to Hasan Alawi Hasan Alawi (= 1×) peers Masahiko Takai

Countries citing papers authored by Hasan Alawi

Since Specialization

Citations

This map shows the geographic impact of Hasan Alawi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hasan Alawi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hasan Alawi more than expected).

Fields of papers citing papers by Hasan Alawi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hasan Alawi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hasan Alawi. The network helps show where Hasan Alawi may publish in the future.

Co-authorship network of co-authors of Hasan Alawi

This figure shows the co-authorship network connecting the top 25 collaborators of Hasan Alawi. A scholar is included among the top collaborators of Hasan Alawi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hasan Alawi. Hasan Alawi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Alotaibi, Mazyad, et al.. (2019). Exploring Drug-Related Problems in Diabetic Patients during Ramadan Fasting in Saudi Arabia: A Mixed-Methods Study. International Journal of Environmental Research and Public Health. 16(3). 499–499. 8 indexed citations

2.

Meneilly, Graydon S., Christine Roy-Duval, Hasan Alawi, et al.. (2017). Lixisenatide Therapy in Older Patients With Type 2 Diabetes Inadequately Controlled on Their Current Antidiabetic Treatment: The GetGoal-O Randomized Trial. Diabetes Care. 40(4). 485–493. 30 indexed citations

3.

Meneilly, Graydon S., Hasan Alawi, George Dailey, et al.. (2016). Lixisenatide Therapy in Older Patients with Type 2 Diabetes Inadequately Controlled on Their Current Anti-Diabetic Treatment: The GetGoal-O Study (NCT01798706). Canadian Journal of Diabetes. 40(5). S45–S45. 2 indexed citations

4.

Schnell, Oliver, Hasan Alawi, Tadej Battelino, et al.. (2013). Self-Monitoring of Blood Glucose in Type 2 Diabetes: Recent Studies. Journal of Diabetes Science and Technology. 7(2). 478–488. 54 indexed citations

5.

Schnell, Oliver, Hasan Alawi, Tadej Battelino, et al.. (2012). The Role of Self-Monitoring of Blood Glucose in Glucagon-like Peptide-1-Based Treatment Approaches: A European Expert Recommendation. Journal of Diabetes Science and Technology. 6(3). 665–673. 10 indexed citations

6.

Schnell, Oliver, Hasan Alawi, Tadej Battelino, et al.. (2011). Addressing Schemes of Self-Monitoring of Blood Glucose in Type 2 Diabetes: A European Perspective and Expert Recommendation. Diabetes Technology & Therapeutics. 13(9). 959–965. 40 indexed citations

7.

Moulin, Philippe, et al.. (2009). Efficacy of benfluorex in combination with sulfonylurea in type 2 diabetic patients: An 18 to 34-week, open-label, extension period. Diabetes & Metabolism. 35(1). 64–70. 2 indexed citations

8.

Moulin, Philippe, et al.. (2006). Efficacy of Benfluorex in Combination With Sulfonylurea in Type 2 Diabetic Patients. Diabetes Care. 29(3). 515–520. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact